EU-US trade deal leaves future of pharma tariffs uncertain
Despite a new EU-US trade deal, tariffs on pharmaceuticals remain uncertain and unchanged for now, pending the outcome of a US national security investigation that could later impose duties of up to 15%.
Despite a new EU-US trade deal, tariffs on pharmaceuticals remain uncertain and unchanged for now, pending the outcome of a US national security investigation that could later impose duties of up to 15%.
What's Your Reaction?
